[Eruptive pseudoangiomatosis in infant and newborns]

B Guillot1, H Chraibi, C Girard

  • 1Service de Dermatologie, Hôpital Saint-Eloi, CHU de Montpellier. b.guillot@chu-montpellier.fr

Insights

Eruptive pseudoangiomatosis presents as a rash in infants, often following infections. This study highlights varied presentations and disease courses, suggesting a non-specific viral cause.

Area of Science:

  • Pediatric Dermatology
  • Infectious Diseases

Background:

  • Eruptive pseudoangiomatosis (EPA) is an acute, non-pruritic rash in children, typically resolving within days.
  • A viral etiology is suspected but remains unproven for EPA.

Observation:

  • Seven infants (5 male, 2 female, aged 8 days to 16 months) presented with EPA.
  • Typical rash distribution involved face and limbs in 6/7 infants; one had facial and back involvement.
  • Rash onset followed infections in 4 cases; one case appeared post-nephroma surgery, and another had familial occurrence.

Findings:

  • Six patients experienced spontaneous resolution within 3-10 days; one had a prolonged course (>9 months).
  • Infectious agent screening was negative in the two tested children.
  • Unique cases included a neonate, a child with renal tumor, and familial rash.

Implications:

  • EPA presents diverse clinical scenarios, including very young infants, co-occurrence with tumors, and familial cases.
  • This series reinforces EPA as a clinical presentation of non-specific viral infections, similar to Giannotti-Crosti syndrome.
  • Further research is needed to identify specific causative agents for eruptive pseudoangiomatosis.
Abstract